According to a new report Europe Biophotonics Market, published by KBV Research, the Europe Biophotonics Market is expected to register a CAGR of 10.1% during the forecast period.
The Medical Diagnostics market dominated the Europe Biophotonics Market in 2015, growing at a CAGR of 8% during the forecast period. The Tests & Components market is expected attain a market size of $2,346.6 million by 2022. The Medical Therapeutics market is anticipated to reach a market size of $3,215.7 million by 2022 growing from a market size of $1,341.6 million in 2015.
The In-Vivo market dominated the Europe Biophotonics Market in 2015, growing at a CAGR of 9.3% during the forecast period. The In-Vitro market is expected to attain a market size of $6,692.2 million by 2022.
The Germany market dominated the Europe Biophotonics Market in 2015, growing at a CAGR of 8.9% during the forecast period. The France market is expected to attain a market size of $2,607.4 million by 2022. However, UK market is expected to grow at CAGR of 8.2% during 2016-2022.
The report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the countries in the region. The key influencing factors of the Europe Biophotonics have been discussed in the report along with the elaborated company profiles of Oxford Instruments, Thermo Fisher Scientific, Lumenis Ltd, Carl Zeiss AG, Olympus Corporation, Hamamatsu Photonics K.K., Becton, Dickinson and Company, Perkinelmer, Inc., and Zecotek Photonics, Inc.
Full report :- https://www.kbvresearch.com/europe-biophotonics-market/
Related Reports-
Asia-Pacific Biophotonics Market
Unique Offerings 
